Condition
Hodgkin Lymphoma, Adult clinical trials and research
Research outlook What's coming for Hodgkin lymphoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 5 Hodgkin Lymphoma, Adult clinical trials that are recruiting, at sites in 3 countries (most in United States (3), Russia (2), India (1)). By phase: Phase 2 (2), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Hodgkin Lymphoma, Adult clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| ctDNA-guided therapy for relapsed or refractory Hodgkin lymphoma using pembrolizumab with GVD | Phase 2 | Davis, California and 5 other locations | Recruiting | Jun 15, 2025 |
| Using nivolumab with AVD for advanced Hodgkin lymphoma | Phase 2 | Moscow | Recruiting | May 22, 2025 |
| Understanding brain function in Hodgkin Lymphoma survivors | — | Memphis, Tennessee | Recruiting | May 20, 2024 |
| Evaluating MT-601 for patients with relapsed or refractory lymphoma | Phase 1 | Duarte, California and 6 other locations | Recruiting | Apr 5, 2023 |
| First line chemotherapy for Hodgkin Lymphoma in Russia | Phase 3 | Mumbai, Opd-81 Main Building, Dr. E Borges Road, Parel 400012 and 1 other locations | Recruiting | Nov 20, 2020 |
All recruiting trials (5)
-
ctDNA-guided therapy for relapsed or refractory Hodgkin lymphoma using pembrolizumab with GVD
This study tests a pembrolizumab-based regimen plus chemotherapy in adults with relapsed or refractory classic Hodgkin lymphoma to see if ctDNA can guide treatment response and consolidation choices.
-
Using nivolumab with AVD for advanced Hodgkin lymphoma
This study is testing if a new combination of nivolumab and AVD chemotherapy can help people with newly diagnosed advanced Hodgkin lymphoma feel better and respond well to treatment.
-
Understanding brain function in Hodgkin Lymphoma survivors
This study is trying to see how treatments for Hodgkin Lymphoma affect brain function in survivors compared to people who haven't had cancer.
-
Evaluating MT-601 for patients with relapsed or refractory lymphoma
This study is testing a new treatment called MT-601 to see if it can help people with relapsed or hard-to-treat lymphoma feel better.
-
First line chemotherapy for Hodgkin Lymphoma in Russia
This study is testing different chemotherapy treatments for adults with Hodgkin Lymphoma in Russia to see which one helps them live longer and feel better.
Related topics
Quick answers
How many Hodgkin Lymphoma, Adult clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (3 trials), Russia (2 trials), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.